Showing results (81-90 of 816) with videos related to
Sort By:
Pageof 82
International Journal of Alzheimer'S Disease|June 11, 2011
Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's DiseasePeter Wostyn, Debby Van Dam, Kurt Audenaert, et al.Dementia and Geriatric Cognitive Disorders Extra|November 1, 2021
Short- and Long-Term Functional Connectivity Differences Associated with Alzheimer's Disease ProgressionJaime D Mondragón, Ramesh Marapin, Peter Paul De Deyn, et al.Journal of Neurochemistry|March 27, 2025
Monoaminergic Alterations at the Subregional Cervical and Thoracic Spinal Cord Level of Patients Within the FTD-ALS Continuum and Early-Onset AD: Low Thoracic Dopaminergic Activity in ALSAnnelies Heylen, Yannick Vermeiren, Peter Paul De Deyn, et al.Data in Brief|March 4, 2022
Loading characteristics data applied on osseointegrated implant by transfemoral bone-anchored prostheses fitted with state-of-the-art components during daily activitiesLaurent Frossard, Stefan Laux, Marta Geada, et al.Aerospace Medicine and Human Performance|November 30, 2018
Dilated Prelaminar Paravascular Spaces as a Possible Mechanism for Optic Disc Edema in AstronautsPeter Wostyn, Frank De Winne, Claudia Stern, et al.Medical Hypotheses|July 20, 2011
Are intracranial pressure fluctuations important in glaucoma?Peter Wostyn, Veva De Groot, Kurt Audenaert, et al.Journal of Neurogenetics|October 26, 2011
Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: a hypothesisPeter Wostyn, Debby van Dam, Kurt Audenaert, et al.Journal of Biomaterials Applications|January 8, 2013
In vivo testing of a bioabsorbable magnesium alloy serving as total ossicular replacement prosthesesRebecca Lensing, Peter Behrens, Peter Paul Müller, et al.Journal of Chromatography. A|May 27, 2014
Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissueDebby Van Dam, Yannick Vermeiren, Tony Aerts, et al.Arzneimittel-Forschung|August 6, 2008
Validation of the APP23 transgenic mouse model of Alzheimer's disease through evaluation of risperidone treatment on aggressive behaviourEllen Vloeberghs, Katrien Coen, Debby Van Dam, et al.Pageof 82